Concepedia

Christopher S. Poss

CS

8

Publications

551

Citations

8

H-Index

1993

Active since

Affiliations

Pfizer (United States)(Current)

Christopher S. Poss is an author at Pfizer (United States) specializing in pharmacology, engineering, and medicine.

Top concepts

Publications per year

1993–2023

8

Publications

8

Two-directional chain synthesis and terminus differentiation

Christopher S. Poss, Stuart L. Schreiber · Accounts of Chemical Research · 1994 · 283 citations

, , +16

CP-481,715, a Potent and Selective CCR1 Antagonist with Potential Therapeutic Implications for Inflammatory Diseases

Ronald P. Gladue, Laurie Tylaska, William H. Brissette et al. · Journal of Biological Chemistry · 2003 · 89 citations · Full text

Two-directional chain synthesis: an application to the synthesis of (+)-mycoticin A

Christopher S. Poss, Scott D. Rychnovsky, Stuart L. Schreiber · Journal of the American Chemical Society · 1993 · 77 citations

, , +15

Novel CCR1 antagonists with improved metabolic stability

Matthew F. Brown, M P Avery, William H. Brissette et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 33 citations · Full text

, , +5

A framework for setting enrollment goals to ensure participant diversity in sponsored clinical trials in the United States

Mark R. Cullen, Adina R. Lemeshow, Sandra Cristina Ferreira Amaro et al. · Contemporary Clinical Trials · 2023 · 25 citations · Full text

Rows per page

1–5 of 8